Izrael - hebrejski - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

Izrael - hebrejski - Ministry of Health

merck sharp & dohme israel ltd - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

Izrael - hebrejski - Ministry of Health

merck serono ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 44 mcg/ml - interferon beta-1a - interferon beta-1a - rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. efficacy of rebif in chronic progressive multiple sclerosis has not been established.

Izrael - hebrejski - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - piroxicam - ג'ל - piroxicam 5 mg/g - piroxicam - piroxicam - variety of conditions characterized by pain and inflammation such as osteoarthritis of superficial joints, acute musculoskeletal injuries, periarthritis, tendinitis and tenosynovitis.

Izrael - hebrejski - Ministry of Health

reckitt benckiser (near east) ltd - ibuprofen - ג'ל - ibuprofen 5 %w/w - ibuprofen - ibuprofen - topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.

Izrael - hebrejski - Ministry of Health

cts ltd - diclofenac sodium - מדבקות - diclofenac sodium 140 mg/patch - diclofenac - diclofenac - dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.

Izrael - hebrejski - Ministry of Health

cts ltd - diclofenac sodium - מדבקות - diclofenac sodium 140 mg - diclofenac - diclofenac - dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.

Izrael - hebrejski - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - lidocaine as hydrochloride; methylprednisolone acetate - תרחיף להזרקה - lidocaine as hydrochloride 10 mg/ml; methylprednisolone acetate 40 mg/ml - methylprednisolone, combinations - lidocaine - depo-medrol with lidocaine is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: - synovitis of osteoarthritis - rheumatoid arthritis - acute and subacute bursitis - acute gouty arthritis - epicondylitis - acute nonspecific tenosynovitis - post-traumatic osteoarthritis.

Izrael - hebrejski - Ministry of Health

rafa laboratories ltd - capsaicin - קרם - capsaicin 0.025 % - capsaicin - capsaicin - treatment of arthritis

Izrael - hebrejski - Ministry of Health

unipharm trading ltd, israel - fluphenazine decanoate - תמיסה להזרקה - fluphenazine decanoate 25 mg/ml - fluphenazine - fluphenazine - management of psychotic disorders.